Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration

Area of Science:

• Biomedical Science
• Cell Biology
• Regenerative Medicine

Background:

• Intervertebral disc degeneration (IVDD) is a primary cause of spinal disorders.
• Cellular senescence and its associated secretory phenotype (SASP) contribute to IVDD by disrupting extracellular matrix (ECM) homeostasis.
• Senescent cells accumulate in degenerated discs, exacerbating the condition.

Purpose of the Study:

• To review the role of cellular senescence in IVDD.
• To discuss the therapeutic potential of senolytics in eliminating senescent disc cells.
• To identify potential senolytic drugs for future IVDD treatment.

Main Methods:

• Literature review on cellular senescence and IVDD.
• Analysis of the impact of SASP on ECM metabolism.
• Compilation of a list of senolytic drugs and small molecules.

Main Results:

• Senescent cells and SASP are key contributors to IVDD pathogenesis.
• Senolytics effectively eliminate senescent cells, offering a potential treatment strategy.
• Several senolytic drugs and small molecules have been identified for potential IVDD therapy.

Conclusions:

• Cellular senescence is a critical factor in IVDD.
• Targeting senescent cells with senolytics presents a promising therapeutic avenue for IVDD.
• Further research into senolytic drugs could lead to novel treatments for spinal degeneration.